5,570 reports of this reaction
2.0% of all ALLOPURINOL reports
#9 most reported adverse reaction
PNEUMONIA is the #9 most commonly reported adverse reaction for ALLOPURINOL, manufactured by Mylan Institutional LLC. There are 5,570 FDA adverse event reports linking ALLOPURINOL to PNEUMONIA. This represents approximately 2.0% of all 274,886 adverse event reports for this drug.
Patients taking ALLOPURINOL who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for ALLOPURINOL, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for ALLOPURINOL:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 5,570 FDA reports for ALLOPURINOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 2.0% of all adverse event reports for ALLOPURINOL, making it a notable side effect.
If you experience pneumonia while taking ALLOPURINOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.